Emerging Treatments in Fight Against COVID-19 .

A rapidly expanding mix of COVID-19 treatment trials is underway, with well over a hundred single and combination therapies being explored. Most activity centers around familiar drug classes such as antimalarials, antivirals, biologics, stem-cell therapies, and convalescent plasma. Despite the volume of research, high-quality trials have yet to identify a clearly effective option. As studies continue, many national agencies are offering cautious or conditional guidance, often limiting use to clinical-trial settings or severe illness. The shared goal across efforts is simple: generate reliable evidence quickly enough to guide care while the pandemic continues to evolve.